Blog Posts

2024 340B Contract Pharmacy Outlook: Expect More State Than Federal Action, Say Attorneys and Lobbyists

US Eighth Circuit Court of Appeals building
A decision upholding Arkansas' state contract pharmacy law from the U.S. 8th Circuit Court of Appeals could cause more states to push similar laws, attorneys and lobbyists said.
Amid expected congressional gridlock, there is a much higher likelihood of state legislative action on 340B contract pharmacies than federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Says Arkansas Agreement ‘Preserves It’s Position’; More Manufacturer Deals in the Works

Arkansas Insurance Department office sign
The Arkansas Insurance Department is considering changes to a temporary settlement with drugmaker Novo Nordisk after hospitals in the state raised concerns.
Drugmaker Novo Nordisk’s deal with Arkansas restoring 340B discounts in the contract pharmacy setting until a coming appeals court ruling, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Government Passes on Appealing Key Patient Definition Ruling

Genesis Health care facility and signage
The Biden administration will not appeal a high-profile November federal court ruling on the 340B patient definition.
The Biden administration will not appeal a high-profile November federal court ruling to prohibit enforcement of a 340B patient definition [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two 340B Terminations, Two Paybacks to Manufacturers in Latest Provider Audit Findings

HRSA provider audits
Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of two more 340B providers.
Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

2024 Congressional 340B Outlook: Overhaul Unlikely Without Major Legal Developments, Senate Deal

US Capitol
Congress is unlikely to pass a 340B program overhaul in 2024 unless there is unexpected pressure from appellate court decisions or a Senate "group of 6" breakthrough, attorneys and lobbyists said.
In 2024, congressional gridlock and election year dynamics will likely slow momentum on any comprehensive 340B program reform package, lobbyists [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Top 10 Most Read 340B Report Articles in 2023

Top 10 graphic image
These are top 10 most read 340B Report articles for 2023.
Among the many tumultuous developments affecting the 340B discount drug program in 2023, the most popular news articles in 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Novo Nordisk, Arkansas Reach Temporary Deal Amid Contract Pharmacy Fight

Arkansas Insurance Department office sign
The Arkansas Insurance Department is considering changes to a temporary settlement with drugmaker Novo Nordisk after hospitals in the state raised concerns.
Novo Nordisk will lift restrictions in Arkansas on 340B providers’ contract pharmacy arrangements and Arkansas will suspend enforcement against the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Gilead Expands 340B Reporting to Wholly Owned Contract Pharmacies

Gilead exterior office sign
Gilead Sciences will expand its data reporting requirements for 340B pricing on branded hepatitis C products to contract pharmacies wholly owned by covered entities.
Drugmaker Gilead Sciences will expand its data reporting requirements for 340B pricing on branded hepatitis C products to contract pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Groups Urge Federal Court to Dismiss Drug Industry Suit Against Louisiana Law

Jeff Landry headshot
Four hospital associations filed an amicus brief in support of Louisiana Attorney General Jeff Landry's defense of his state's contract pharmacy law.
Four hospital associations are asking a federal judge in Louisiana to throw out a suit filed by the drug industry [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report